Guide: Beam Therapeutics down as it acquires GuideTx
US biotech Beam Therapeutics saw its shares fall 12.6% to $96.48 yesterday, after it announced it has...
Read full article »
Guide Therapeutics is a Georgia-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of serious diseases.
Read more